P. D. J. Vegt

Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer

Elizabeth C. de Boer, Wim H. de Jong, P. A. Steerenberg et al. · Cancer Immunology Immunotherapy · 1992 · 198 citations · Full text

Tumour Necrosis Factor, Urology, Cancer Immunosurveillance +7

Original Articles: Bladder Cancer: A Randomized Study of Intravesical Mitomycin C, Bacillus Calmette-Guerin Tice and Bacillus Calmette-Guerin RIVM Treatment in pTa-pT1 Papillary Carcinoma and Carcinoma in Situ of the Bladder

P. D. J. Vegt, J. Alfred Witjes, Wim P.J. Witjes et al. · The Journal of Urology · 1995 · 123 citations

Surgical Oncology, Mitomycin C, Pathology +17

Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin

Elizabeth C. de Boer, Wim H. de Jong, A.P.M. van der Meijden et al. · Cancer Immunology Immunotherapy · 1991 · 111 citations · Full text

Urological Research, Urology, Genitourinary Cancer +8

Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer

Elizabeth C. de Boer, Wim H. de Jong, A.P.M. van der Meijden et al. · Urological Research · 1991 · 100 citations

Urological Research, Urology, Genitourinary Cancer +7

Does Isoniazid Reduce Side Effects of Intravesical Bacillus Calmette-Guerin Therapy in Superficial Bladder Cancer? Interim Results of European Organization for Research and Treatment of Cancer Protocol 30911

P. D. J. Vegt, Adrian P.M. van der Meijden, Richard Sylvester et al. · The Journal of Urology · 1997 · 90 citations